Good Days is excited to announce that the 2020 Re-Enrollment Campaign is now open! Please click HERE to re-enroll for assistance. Due to high call volume during this time, we highly encourage you to utilize our online tool for re-enrollment.

 
Diseases Covered

Spinal Muscular Atrophy

All pictures shown are used for illustrative purposes only.

Program Status

open

Apply Now

Assistance Amount

$ 100,000

Ask your Good Days Patient Care Navigator for more information.

Eligibility Criteria

  • Patient must be diagnosed with a covered disease and program must be accepting enrollments
  • Patient must have a valid Social Security number to apply for assistance and receive treatment in the United States
  • Patient must be seeking assistance for a prescribed medication that is FDA approved to treat the covered diagnosis
  • Patient must have valid Medicare, Medicaid or Military insurance coverage
  • Patient income level must be at or below 500% of the Federal Poverty Level (FPL)

Apply Now

Support Organizations

These organizations do not offer co-pay assistance, but they offer valuable information and support.

  • Prednisolone
  • Spinraza
  • Zolgensma

Spinal muscular atrophy (SMA) is a group of hereditary diseases that progressively destroys motor neurons—nerve cells in the brain stem and spinal cord that control essential skeletal muscle activity such as speaking, walking, breathing, and swallowing, leading to muscle weakness and atrophy. (Source: National Institute of Neurological Disorders and Stroke; Spinal Muscular Atrophy Fact Sheet)

Support Organizations

These organizations do not offer co-pay assistance, but they offer valuable information and support.

Medications Covered

  • Prednisolone
  • Spinraza
  • Zolgensma

Disease Description

Spinal muscular atrophy (SMA) is a group of hereditary diseases that progressively destroys motor neurons—nerve cells in the brain stem and spinal cord that control essential skeletal muscle activity such as speaking, walking, breathing, and swallowing, leading to muscle weakness and atrophy. (Source: National Institute of Neurological Disorders and Stroke; Spinal Muscular Atrophy Fact Sheet)